CN105250375A - Composition for treating herpes zoster - Google Patents
Composition for treating herpes zoster Download PDFInfo
- Publication number
- CN105250375A CN105250375A CN201510845877.5A CN201510845877A CN105250375A CN 105250375 A CN105250375 A CN 105250375A CN 201510845877 A CN201510845877 A CN 201510845877A CN 105250375 A CN105250375 A CN 105250375A
- Authority
- CN
- China
- Prior art keywords
- parts
- herpes zoster
- composition
- radix
- roots
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000007514 Herpes zoster Diseases 0.000 title claims abstract description 16
- 241000628997 Flos Species 0.000 claims abstract description 5
- 239000010231 banlangen Substances 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 229940098465 tincture Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 1
- 206010004542 Bezoar Diseases 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- 102000006601 Thymidine Kinase Human genes 0.000 description 1
- 108020004440 Thymidine kinase Proteins 0.000 description 1
- HDOVUKNUBWVHOX-QMMMGPOBSA-N Valacyclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCOC(=O)[C@@H](N)C(C)C)C=N2 HDOVUKNUBWVHOX-QMMMGPOBSA-N 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 229960004396 famciclovir Drugs 0.000 description 1
- GGXKWVWZWMLJEH-UHFFFAOYSA-N famcyclovir Chemical compound N1=C(N)N=C2N(CCC(COC(=O)C)COC(C)=O)C=NC2=C1 GGXKWVWZWMLJEH-UHFFFAOYSA-N 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000005156 neurotropism Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000010181 polygamy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 210000001032 spinal nerve Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229940093257 valacyclovir Drugs 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000009306 yunnan baiyao Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a composition for treating herpes zoster. The composition is prepared from, by mass, 10-20 parts of isatis roots, 15-40 parts of licorice roots, 20-30 parts of angelica dahurica, 15-30 parts of red-rooted salvia roots, 15-30 parts of flos chrysanthemi indici and 10-20 parts of asarum. The composition has good therapeutic action on herpes zoster, and no obvious toxic or side effect exists.
Description
Technical field
The invention belongs to biomedicine field, be specifically related to a kind of prescription for the treatment of herpes zoster.
Background technology
Herpes zoster is the acute inflammation dermatoses caused by varicella zoster virus, and the traditional Chinese medical science is called " skirt-roof HUOLONG ", " herpes zoster ".After infected to this viral child without immunity, there is chickenpox.Become carrier after some patients is infected and symptom do not occur.Because virus has neurotropism, can hide for a long time in the neuron of spinal nerves posterior root ganglion after infection, when lower for the resistance or tired, infection, flu, virus can regrow breeding, and move to skin along nerve fiber, make the nerve of being invaded and skin produce strong inflammation.Herpes zoster has feature that is Unilateral and that distribute by nerve segment, is made up of the herpes of collection bunch property, and with pain, the age is larger, and neuralgia is heavier.Primary disease is apt to occur in adult, and season in spring and autumn is common.Sickness rate increases with the age and rises in remarkable.
At present for the treatment of herpes zoster, doctor trained in Western medicine mainly takes antiviral therapy and pain management, and object prevents secondary infection, shortens the course of disease, improves patient pain's symptom etc.Antiviral therapy common drug has acyclovir, famciclovir, valaciclovir etc., said medicine can act on thymidine kinase, preventing viral DNA replication dna, reduces gradient of infection and virus replication, thus reduces the appearance of new focus and promote skin lesion incrustation.Also normal merging uses various Analgesic techniques to treat herpes zoster clinically, and conventional analgesic drug product comprises diclofenac, indometacin, somedon etc.
Chinese medicine is thought, herpes zoster is due to feelings will internal injury, the liver losing its smoothly moving state, dysfunction of the spleen in transportation, drinking and eating irregularly, causes incoordination between the liver and spleen, stagnation of QI damp-stagnancy, fire-transformation outgoing, the fiery wound of damp and hot poison caused by the skin.Treatment according to the different times Coryza Treated by Syndrome Differentiation of morbidity, should be considered in conjunction with herpes episodes feature and individual patients combined factors simultaneously.A large amount of clinical practice proves: illly select treatment by Chinese herbs in early days, can eliminate erythra fast, avoids local severe pain.The report that XIAOJIN DAN, YUNNAN BAIYAO, LIUSHEN WAN, zijin troche, nantong sheyao, BINGPENG SAN, cow-bezoar anti-toxic bolus etc. are used for the treatment of herpes zoster is more, and also polygamy closes endo-medicine treatment, and its good effect, expense is lower.
Summary of the invention
Comprehensive state of the art and Problems existing, the object of the present invention is to provide a kind of prescription for the treatment of herpes zoster, and the present invention is pure Chinese medicinal preparation, has good therapeutical effect to herpes zoster, and without obvious toxic-side effects.
For achieving the above object, the present invention is made up of the raw material of following masses ratio: Radix Isatidis 10-20 part, Radix Glycyrrhizae 15-40 part, Radix Angelicae Dahuricae 20-30 part, Radix Salviae Miltiorrhizae 15-30 part, Flos Chrysanthemi Indici 15-30 part, Herba Asari 10-20 part.The preferred tincture of form of administration of the present invention, such as with 5-10, doubly 75% soak with ethanol is stand-by after one week, puts on the skin outward.
Detailed description of the invention
Embodiment 1. the present invention be made up of the raw material of following masses ratio: Radix Isatidis 10 parts, 40 parts, Radix Glycyrrhizae, the Radix Angelicae Dahuricae 20 parts, Radix Salviae Miltiorrhizae 30 parts, Flos Chrysanthemi Indici 15 parts, Herba Asari 20 parts.
Embodiment 2. the present invention be made up of the raw material of following masses ratio: Radix Isatidis 20 parts, 15 parts, Radix Glycyrrhizae, the Radix Angelicae Dahuricae 30 parts, Radix Salviae Miltiorrhizae 15 parts, Flos Chrysanthemi Indici 30 parts, Herba Asari 10 parts.
Claims (2)
1. treat a prescription for herpes zoster, be made up of the raw material of following masses ratio: Radix Isatidis 10-20 part, Radix Glycyrrhizae 15-40 part, Radix Angelicae Dahuricae 20-30 part, Radix Salviae Miltiorrhizae 15-30 part, Flos Chrysanthemi Indici 15-30 part, Herba Asari 10-20 part.
2. a kind of prescription for the treatment of herpes zoster according to claim 1, is characterized in that: described form of administration is tincture.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510845877.5A CN105250375A (en) | 2015-11-27 | 2015-11-27 | Composition for treating herpes zoster |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510845877.5A CN105250375A (en) | 2015-11-27 | 2015-11-27 | Composition for treating herpes zoster |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105250375A true CN105250375A (en) | 2016-01-20 |
Family
ID=55090511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510845877.5A Pending CN105250375A (en) | 2015-11-27 | 2015-11-27 | Composition for treating herpes zoster |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105250375A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1461649A (en) * | 2002-05-28 | 2003-12-17 | 杨毓龙 | Medicine for treating herpes zoster |
| CN1509741A (en) * | 2002-12-23 | 2004-07-07 | 上海中华制药厂 | Chinese medicinal preparation for preventing herpes virus and preparing method thereof |
| CN100998804A (en) * | 2006-12-28 | 2007-07-18 | 江蕾 | Oral Chinese medicine for treating damp-heat type shingles |
| CN101181366A (en) * | 2007-11-26 | 2008-05-21 | 仲海崑 | Chinese medicine composition oral administration and externally used for curing zoster |
| CN101485710A (en) * | 2008-01-14 | 2009-07-22 | 上海中药制药技术有限公司 | Chinese medicinal composition for treating herpes zoster |
| CN102430071A (en) * | 2011-12-07 | 2012-05-02 | 黄炳炎 | Medicament for treating herpes zoster |
| CN102697903A (en) * | 2012-05-11 | 2012-10-03 | 贾晋科 | Medicine for treating herpes zoster |
-
2015
- 2015-11-27 CN CN201510845877.5A patent/CN105250375A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1461649A (en) * | 2002-05-28 | 2003-12-17 | 杨毓龙 | Medicine for treating herpes zoster |
| CN1509741A (en) * | 2002-12-23 | 2004-07-07 | 上海中华制药厂 | Chinese medicinal preparation for preventing herpes virus and preparing method thereof |
| CN100998804A (en) * | 2006-12-28 | 2007-07-18 | 江蕾 | Oral Chinese medicine for treating damp-heat type shingles |
| CN101181366A (en) * | 2007-11-26 | 2008-05-21 | 仲海崑 | Chinese medicine composition oral administration and externally used for curing zoster |
| CN101485710A (en) * | 2008-01-14 | 2009-07-22 | 上海中药制药技术有限公司 | Chinese medicinal composition for treating herpes zoster |
| CN102430071A (en) * | 2011-12-07 | 2012-05-02 | 黄炳炎 | Medicament for treating herpes zoster |
| CN102697903A (en) * | 2012-05-11 | 2012-10-03 | 贾晋科 | Medicine for treating herpes zoster |
Non-Patent Citations (1)
| Title |
|---|
| 胡郁坤等: "《中医单方全书（珍藏本）超值版》", 30 June 2012, 湖南科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103393966B (en) | A kind of Chinese medicine composition for the treatment of menoxenia | |
| CN104042761B (en) | A kind of Chinese medicine composition for the treatment of herpes zoster | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN103446554A (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
| CN105250362A (en) | Traditional Chinese medicine for treating herpes zoster | |
| CN105250413A (en) | Traditional Chinese medicine for treating herpes zoster | |
| CN102698220A (en) | Traditional Chinese medicine formula for treating scapulohumeral periarthritis | |
| CN102688393B (en) | Traditional Chinese medicine for treating verruca plana and preparation method thereof | |
| CN105250375A (en) | Composition for treating herpes zoster | |
| CN105311105A (en) | Composition for treating herpes zoster | |
| CN103893502A (en) | Traditional Chinese medicine for treating phlyctenular conjunctivitis | |
| CN105250396A (en) | Traditional Chinese medicine formula for treating herpes zoster | |
| CN105311073A (en) | Medicine for treating herpes zoster | |
| CN105380972A (en) | Medicine for treating herpes zoster | |
| CN105287764A (en) | Compound preparation for treating herpes zoster | |
| CN105381009A (en) | Herpes zoster curative drug | |
| CN103432220B (en) | Traditional Chinese medicine preparation for treating aching and preparation method thereof | |
| CN105641128A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN104491072A (en) | Traditional Chinese medicine for treating nerve-root type cervical spondylosis | |
| CN104274603A (en) | Traditional Chinese medicine for treating leg cramps | |
| CN103127414B (en) | Drug for treatment of chronic nephritis and early stage renal failure | |
| CN104645087A (en) | Traditional Chinese medicine composition for treating postherpetic neuralgia | |
| CN103301429B (en) | Oral preparation for treating women dysmenorrhea | |
| CN104784626A (en) | Chinese and Western medicine used for treating herpes zoster, and application method thereof | |
| CN102716273A (en) | Application of compound rhizoma corydalis decumbentis tablet in preparing medicine for preventing and curing coronary heart disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160120 |